Table 1 Clinical characteristics and echocardiographic data of two groups

From: Inappropriateness of ventricular hypertrophy is important as a determinant of BNP but not of diastolic filling in untreated hypertensive patients

 

oLVM/pLVM100

oLVM/pLVM>100

Number

38

39

Age, years

59±12

58±13

Gender, F/M

13/25

16/23

BSA, m2

1.6±0.2

1.7±0.2

SBP, mm Hg

167±20

158±16a

DBP, mm Hg

95±13

93±9

HR, beats per minute

65±9

66±10

CRE, mg per 100 ml

0.68±0.14

0.70±0.14

eGFR, ml min−1 per 1.73 m2

84±16

80±17

BNP, pg ml−1

26±29

26±22

LAD, mm

36±5

39±6a

Systolic wall stress

49±12

45±12

LVMI, g m−2

96±19

117±20a

RWT

0.38±0.03

0.43±0.05a

E, cm s−1

63±14

60±13

A, cm s−1

71±14

68±15

E/A

0.91±0.28

0.93±0.29

DcT, ms

205±49

209±39

E′, cm s−1

5.9±1.3

5.4±1.4

E/E′

11±3

12±3

  1. Abbreviations: BNP, brain natriuretic peptide; BSA, body surface area; CRE, serum creatinine; DBP, diastolic blood pressure; DcT, deceleration time of E wave; E, peak early diastolic flow velocity of mitral flow; E′, peak early diastolic velocity of mitral annulus; E/A, the ratio of E to A; E/E′, the ratio of E to E′; eGFR, estimated glomerular filtration rate; F, female; HR, heart rate; LAD, left atrial dimension; LVMI, left ventricular mass index; M, male; oLVM, observed left ventricular mass; pLVM, predicted left ventricular mass; RWT, relative wall thickness; SBP, systolic blood pressure.
  2. aP<0.05 vs. oLVM/pLVM100.